Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Torrent Pharmaceuticals Statistics

Total Valuation

NSE:TORNTPHARM has a market cap or net worth of INR 1.27 trillion. The enterprise value is 1.29 trillion.

Market Cap	1.27T
Enterprise Value	1.29T

Important Dates

The next estimated earnings date is Friday, January 23, 2026.

Earnings Date	Jan 23, 2026
Ex-Dividend Date	Jun 20, 2025

Share Statistics

Current Share Class	338.45M
Shares Outstanding	n/a
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.28%
Owned by Institutions (%)	16.69%
Float	103.96M

Valuation Ratios

The trailing PE ratio is 59.36 and the forward PE ratio is 46.34.

PE Ratio	59.36
Forward PE	46.34
PS Ratio	10.37
PB Ratio	15.04
P/TBV Ratio	31.25
P/FCF Ratio	93.53
P/OCF Ratio	65.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.49, with an EV/FCF ratio of 95.03.

EV / Earnings	60.31
EV / Sales	10.54
EV / EBITDA	32.49
EV / EBIT	40.49
EV / FCF	95.03

Financial Position

The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.33.

Current Ratio	1.40
Quick Ratio	0.67
Debt / Equity	0.33
Debt / EBITDA	0.71
Debt / FCF	2.08
Interest Coverage	14.73

Financial Efficiency

Return on equity (ROE) is 26.83% and return on invested capital (ROIC) is 18.20%.

Return on Equity (ROE)	26.83%
Return on Assets (ROA)	13.02%
Return on Invested Capital (ROIC)	18.20%
Return on Capital Employed (ROCE)	28.77%
Revenue Per Employee	7.18M
Profits Per Employee	1.25M
Employee Count	17,059
Asset Turnover	0.80
Inventory Turnover	1.26

Taxes

In the past 12 months, NSE:TORNTPHARM has paid 7.45 billion in taxes.

Income Tax	7.45B
Effective Tax Rate	25.81%

Stock Price Statistics

The stock price has increased by +15.79% in the last 52 weeks. The beta is 0.14, so NSE:TORNTPHARM's price volatility has been lower than the market average.

Beta (5Y)	0.14
52-Week Price Change	+15.79%
50-Day Moving Average	3,628.61
200-Day Moving Average	3,391.78
Relative Strength Index (RSI)	55.03
Average Volume (20 Days)	287,261

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:TORNTPHARM had revenue of INR 122.48 billion and earned 21.40 billion in profits. Earnings per share was 63.23.

Revenue	122.48B
Gross Profit	92.70B
Operating Income	31.88B
Pretax Income	28.85B
Net Income	21.40B
EBITDA	39.48B
EBIT	31.88B
Earnings Per Share (EPS)	63.23

Balance Sheet

The company has 7.94 billion in cash and 28.22 billion in debt, giving a net cash position of -20.28 billion.

Cash & Cash Equivalents	7.94B
Total Debt	28.22B
Net Cash	-20.28B
Net Cash Per Share	n/a
Equity (Book Value)	84.49B
Book Value Per Share	249.47
Working Capital	17.57B

Cash Flow

In the last 12 months, operating cash flow was 19.40 billion and capital expenditures -5.82 billion, giving a free cash flow of 13.58 billion.

Operating Cash Flow	19.40B
Capital Expenditures	-5.82B
Free Cash Flow	13.58B
FCF Per Share	n/a

Margins

Gross margin is 75.69%, with operating and profit margins of 26.03% and 17.47%.

Gross Margin	75.69%
Operating Margin	26.03%
Pretax Margin	23.55%
Profit Margin	17.47%
EBITDA Margin	32.23%
EBIT Margin	26.03%
FCF Margin	11.09%

Dividends & Yields

This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 0.85%.

Dividend Per Share	32.00
Dividend Yield	0.85%
Dividend Growth (YoY)	14.29%
Years of Dividend Growth	1
Payout Ratio	50.60%
Buyback Yield	-0.00%
Shareholder Yield	0.85%
Earnings Yield	1.68%
FCF Yield	1.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 8, 2022. It was a forward split with a ratio of 2.

Last Split Date	Jul 8, 2022
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	7